194 related articles for article (PubMed ID: 35167141)
1. Development of a novel castration-resistant orthotopic prostate cancer model in New Zealand White rabbit.
Wang Y; Abenojar EC; Wang J; de Leon AC; Tavri S; Wang X; Gopalakrishnan R; Walker E; MacLennan GT; Giles A; Czarnota GJ; Basilion JP; Exner AA
Prostate; 2022 May; 82(6):695-705. PubMed ID: 35167141
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a photodynamic therapy agent using a canine prostate cancer model.
Luo D; Wang X; Ramamurthy G; Walker E; Zhang L; Shirke A; Naidu NG; Burda C; Shakya R; Hostnik ET; Joseph M; Ponsky L; Ponomarev V; Rosol TJ; Tweedle MF; Basilion JP
Prostate; 2023 Sep; 83(12):1176-1185. PubMed ID: 37211857
[TBL] [Abstract][Full Text] [Related]
3. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
4. Multispecies comparative prostate anatomy by imaging: Implications for experimental models of prostatic disease.
Berg FM; Correia ETO; Abenojar EC; Basilion JP; Rosol TJ; Baroni RH; Exner AA; Bittencourt LK
Prostate; 2024 May; 84(7):682-693. PubMed ID: 38477025
[TBL] [Abstract][Full Text] [Related]
5. Optimized Anti-Prostate-Specific Membrane Antigen Single-Chain Variable Fragment-Loaded Nanobubbles as a Novel Targeted Ultrasound Contrast Agent for the Diagnosis of Prostate Cancer.
Ding Y; Cao Q; Qian S; Chen X; Xu Y; Chen J; Shen H
J Ultrasound Med; 2020 Apr; 39(4):761-773. PubMed ID: 31702068
[TBL] [Abstract][Full Text] [Related]
6. Ultrasound-mediated drug-free theranostics for treatment of prostate cancer.
Perera RH; Berg FM; Abenojar EC; Nittayacharn P; Kim Y; Wang X; Basilion JP; Exner AA
bioRxiv; 2023 Sep; ():. PubMed ID: 37745586
[TBL] [Abstract][Full Text] [Related]
7. Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55.
Tardy I; Pochon S; Theraulaz M; Emmel P; Passantino L; Tranquart F; Schneider M
Invest Radiol; 2010 Oct; 45(10):573-8. PubMed ID: 20808233
[TBL] [Abstract][Full Text] [Related]
8. Contrast enhanced ultrasound (CEUS) with MRI image fusion for monitoring focal therapy of prostate cancer with high intensity focused ultrasound (HIFU)1.
Apfelbeck M; Clevert DA; Ricke J; Stief C; Schlenker B
Clin Hemorheol Microcirc; 2018; 69(1-2):93-100. PubMed ID: 29660918
[TBL] [Abstract][Full Text] [Related]
9. Establishment of an orthotopic prostate cancer xenograft mouse model using microscope-guided orthotopic injection of LNCaP cells into the dorsal lobe of the mouse prostate.
Liu W; Zhu Y; Ye L; Zhu Y; Wang Y
BMC Cancer; 2022 Feb; 22(1):173. PubMed ID: 35168543
[TBL] [Abstract][Full Text] [Related]
10. Molecular imaging of orthotopic prostate cancer with nanobubble ultrasound contrast agents targeted to PSMA.
Wang Y; De Leon AC; Perera R; Abenojar E; Gopalakrishnan R; Basilion JP; Wang X; Exner AA
Sci Rep; 2021 Feb; 11(1):4726. PubMed ID: 33633232
[TBL] [Abstract][Full Text] [Related]
11. Real time ultrasound molecular imaging of prostate cancer with PSMA-targeted nanobubbles.
Perera RH; de Leon A; Wang X; Wang Y; Ramamurthy G; Peiris P; Abenojar E; Basilion JP; Exner AA
Nanomedicine; 2020 Aug; 28():102213. PubMed ID: 32348874
[TBL] [Abstract][Full Text] [Related]
12. The effects of percutaneous ethanol injection followed by 20-kHz ultrasound and microbubbles on rabbit hepatic tumors.
Shen ZY; Xia GL; Wu MF; Ji LY; Li YJ
J Cancer Res Clin Oncol; 2016 Feb; 142(2):373-8. PubMed ID: 26306908
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetic modeling of PSMA-targeted nanobubbles for quantification of extravasation and binding in mice models of prostate cancer.
Chen C; Perera R; Kolios MC; Wijkstra H; Mischi M; Exner AA; Turco S
Med Phys; 2022 Oct; 49(10):6547-6559. PubMed ID: 36049109
[TBL] [Abstract][Full Text] [Related]
14. Quantitative volumetric imaging of normal, neoplastic and hyperplastic mouse prostate using ultrasound.
Singh S; Pan C; Wood R; Yeh CR; Yeh S; Sha K; Krolewski JJ; Nastiuk KL
BMC Urol; 2015 Sep; 15():97. PubMed ID: 26391476
[TBL] [Abstract][Full Text] [Related]
15. Porphyrin-grafted Lipid Microbubbles for the Enhanced Efficacy of Photodynamic Therapy in Prostate Cancer through Ultrasound-controlled
You Y; Liang X; Yin T; Chen M; Qiu C; Gao C; Wang X; Mao Y; Qu E; Dai Z; Zheng R
Theranostics; 2018; 8(6):1665-1677. PubMed ID: 29556348
[TBL] [Abstract][Full Text] [Related]
16. High-resolution ultrasound allows percutaneous initiation and surveillance of prostate cancer in an orthotopic murine model.
Körbel C; Jung V; Kamradt J; Stöckle M; Unteregger G; Menger MD; Saar M
Urol Int; 2015; 94(3):347-53. PubMed ID: 25115765
[TBL] [Abstract][Full Text] [Related]
17. Vascular endothelial growth factor receptor 2-specific microbubbles for molecular ultrasound detection of prostate cancer in a rat model.
Fischer T; Thomas A; Tardy I; Schneider M; Hünigen H; Custodis P; Beyersdorff D; Plendl J; Schnorr J; Diekmann F; Gemeinhardt O
Invest Radiol; 2010 Oct; 45(10):675-84. PubMed ID: 20733504
[TBL] [Abstract][Full Text] [Related]
18. Multimodality Hyperpolarized C-13 MRS/PET/Multiparametric MR Imaging for Detection and Image-Guided Biopsy of Prostate Cancer: First Experience in a Canine Prostate Cancer Model.
Bachawal SV; Park JM; Valluru KS; Loft MD; Felt SA; Vilches-Moure JG; Saenz YF; Daniel B; Iagaru A; Sonn G; Cheng Z; Spielman DM; Willmann JK
Mol Imaging Biol; 2019 Oct; 21(5):861-870. PubMed ID: 30793241
[TBL] [Abstract][Full Text] [Related]
19. Multiparametric MRI in detection and staging of prostate cancer.
Boesen L
Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
[TBL] [Abstract][Full Text] [Related]
20. Six-Transmembrane Epithelial Antigen of the Prostate-1 (STEAP-1)-Targeted Ultrasound Imaging Microbubble Improves Detection of Prostate Cancer In Vivo.
Yuan Y; Liu Y; Zhu XM; Hu J; Zhao CY; Jiang F
J Ultrasound Med; 2019 Feb; 38(2):299-305. PubMed ID: 30027616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
